Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("DEVITA VT")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 53

  • Page / 3
Export

Selection :

  • and

OSTEONECROSIS OF THE FEMORAL HEAD IN PATIENTS WITH LYMPHOMA TREATED WITH INTERMITTENT COMBINATION CHEMOTHERAPY (INCLUDING CORTICOSTEROIDS). = OSTEONECROSE DE LA TETE DU FEMUR CHEZ LES MALADES AVEC UN LYMPHOME TRAITES PAR LA CHIMIOTHERAPIE D'ASSOCIATION INTERMITTENTE (COMPRENANT DES CORTICOSTEROIDESIHDE DC; DEVITA VT.1975; CANCER; U.S.A.; DA. 1975; VOL. 36; NO 5; PP. 1585-1588; BIBL. 17 REF.Article

THE RELATIONSHIP BETWEEN TUMOR MASS AND RESISTANCE TO CHEMOTHERAPY: IMPLICATIONS FOR SURGICAL ADJUVANT TREATMENT OF CANCER = RELATIONS ENTRE LA MASSE TUMORALE ET LA RESISTANCE A LA CHIMIOTHERAPIE. APPLICATIONS AUX TRAITEMENTS ADJUVANTS A LA CHIRURGIE DES TUMEURS MALIGNESDEVITA VT JR.1983; CANCER; ISSN 0008-543X; USA; DA. 1983; VOL. 51; NO 7; PP. 1209-1220; ABS. ENG; BIBL. 61 REF.; GRAPHArticle

IN VIVO TUMOR CELL KINETIC STUDIES. USE OF LOCAL THYMIDINE INJECTION FOLLOWED BY FINE-NEEDLE ASPIRATION = ETUDE LA CINETIQUE DES CELLULES TUMORALES IN VIVO: UTILISATION D'UNE INJECTION LOCALE DE THYMIDINE SUIVIE D'ASPIRATION A L'AIGUILLE FINEMUGGIA FM; DEVITA VT.1972; J. LAB. CLIN. MED.; U.S.A.; DA. 1972; VOL. 80; NO 2; PP. 297-301; BIBL. 9REF.Serial Issue

HODGKIN'S DISEASE: AN OVERVIEWLEWIS BJ; DEVITA VT JR.1978; SOUTH. MED. J.; USA; DA. 1978; VOL. 71; NO 12; PP. 1546-1552; BIBL. 26 REF.Article

THE EVOLUTION OF PRIMARY MULTIMODALITY TREATMENT IN RESECTABLE BREAST CANCERHENNEY JE; DEVITA VT JR.1980; CANCER; ISSN 0008-543X; USA; DA. 1980; VOL. 46; NO 4; PP. 999-1008; BIBL. 36 REF.Article

LYMPHOMASLONGO DL; DEVITA VT JR.1982; CANCER CHEMOTHERAPY; ISSN 505242; NLD; DA. 1982; NO 4; PP. 197-234; BIBL. 209 REF.Article

THE DESIGN OF CLINICAL TRIALS IN THE THERAPY OF OVARIAN CARCINOMAYOUNG RC; DEVITA VT JR.1974; AMER. J. OBSTETR. GYNECOL.; U.S.A.; DA. 1974; VOL. 120; NO 8; PP. 1012-1024; BIBL. 37 REF.Article

CHRONIC GRANULOCYTIC LEUKEMIA WITHOUT THE PHILADELPHIA CHROMOSOMECANELLOS GP; WHANG PENG; DEVITA VT et al.1976; AMER. J. CLIN. PATHOL.; U.S.A.; DA. 1976; VOL. 65; NO 4; PP. 467-470; BIBL. 13 REF.Article

IN VITRO GRANULOCYTE PRODUCTION IN PATIENTS WITH HODGKIN'S DISEASE AND LYMPHOCYTIC, HISTIOCYTIC, AND MIXED LYMPHOMAS = PRODUCTION IN VITRO DE GRANULOCYTES CHEZ LES MALADES AYANT UNE MALADIE DE HODGKIN, ET CEUX AYANT DES LYMPHOMES LYMPHOCYTAIRES, HISTIOCYTAIRES, ET MIXTESBULL JM; DEVITA VT; CARBONE PP et al.1975; BLOOD; U.S.A.; DA. 1975; VOL. 45; NO 6; PP. 833-842; BIBL. 15REF.Article

THE EFFECT OF CHEMOTHERAPY ON THE GROWTH OF LEUKEMIA L1210. II. PERSISTENCE OF A NITROSOUREA-INDUCED CHANGE IN THE GROWTH CHARACTERISTICS OF TRANSPLANT GENERATIONS = EFFET DE LA CHIMIOTHERAPIE SUR LA CROISSANCE DE LA LEUCEMIE L1210. II. PERSISTENCE D'UNE MODIFICATION INDUITE PAR LA NITROSOUREE DANS LES CARACTERISTIQUES DE CROISSANCE DES GENERATIONS DE TRANSPLANTSDEVITA VT; BRAY DA; BOSTICK F et al.1972; CELL TISSUE KINET.; G.B.; DA. 1972; VOL. 5; NO 6; PP. 459-566; BIBL. 9 REF.Serial Issue

MULTIMODAL TREATMENT OF PRIMARY BREAST CARCINOMA: ANALYSIS OF ACCOMPLISHMENTS AND PROBLEM AREASWEISS RB; HENNEY JE; DEVITA VT JR et al.1981; AM. J. MED.; ISSN 0002-9343; USA; DA. 1981; VOL. 70; NO 4; PP. 844-851; BIBL. 69 REF.Article

COMBINATION CHEMOTHERAPY FOR ADVANCED HODGKIN'S DISEASE IN RELAPSE FOLLOWING EXTENSIVE RADIOTHERAPY = CHIMIOTHERAPIE ASSOCIEE POUR LA MALADIE DE HODGKIN AU STADE AVANCE, AU COURS DE LA RECHUTE CONSECUTIVE A UNE RADIOTHERAPIE IMPORTANTECANELLOS GP; YOUNG RC; DEVITA VT et al.1972; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1972; VOL. 13; NO 5, PART I; PP. 750-754; BIBL. 11REF.Serial Issue

THE ROLE OF COMBINED MODALITY THERAPY IN THE TREATMENT OF STAGE IIIA HODGKIN'S DISEASEDEVITA VT JR; PROSNITZ LR; GLICK JH et al.1979; INTERNATION. J. RAD. ONCOL. BIOL. PHYS.; USA; DA. 1979; VOL. 5; NO 6; PP. 913-914; BIBL. 6 REF.Article

SCREENING OF ANTICANCER DRUGS. V: HISTORICAL DEVELOPMENT AND CURRENT STRATEGY OF THE NATIONAL CANCER INSTITUTE DRUG DEVELOPMENT PROGRAMGOLDIN A; SCHEPARTZ SA; VENDITTI JM et al.1979; METHODS CANCER RES.; USA; DA. 1979; VOL. 16; PP. 165-245; BIBL. 4 P.Article

COMBINATION CHEMOTHERAPY AND SURVIVAL IN ADVANCED HODGKIN'S DISEASECANELLOS GP; YOUNG RC; BERARD CW et al.1973; ARCH. INTERN. MED.; U.S.A.; DA. 1973; VOL. 131; NO 3; PP. 388-390; BIBL. 18REF.Serial Issue

PHARMACOKINETIC RATIONALE FOR PERITONEAL DRUG ADMINISTRATION IN THE TREATMENT OF OVARIAN CANCER.DEDRICK RL; MYERS CE; BUNGARY PM et al.1978; CANCER TREATM. REP.; U.S.A.; DA. 1978; VOL. 62; NO 1; PP. 1-11; BIBL. 24 REF.Article

MENINGEAL LEUKEMIA IN THE BLASTIC PHASE OF CHRONIC GRANULOCYTIC LEUKEMIA = LEUCEMIE MENINGEE A LA PHASE BLASTIQUE D'UNE LEUCEMIE GRANULOCYTAIRE CHRONIQUESCHWARTZ JH; CANELLOS GP; YOUNG RC et al.1975; AMER. J. MED.; U.S.A.; DA. 1975; VOL. 59; NO 6; PP. 819-828; BIBL. 23 REF.Article

HL-A ANTIGENS IN HODGKIN'S DISEASE: HISTOPATHOLOGIC AND CLINICAL CORRELATIONSGRAFF KS; SIMON RM; YANKEE RA et al.1974; J. NATION. CANCER. INST.; U.S.A.; DA. 1974; VOL. 52; NO 4; PP. 1087-1090; BIBL. 41REF.Article

CLINICAL PHARMACOLOGY OF CYCLOPHOSPHAMIDE = PHARMACOLOGIE CLINIQUE DU CYCLOPHOSPHAMIDEBAGLEY CM JR; BOSTICK FW; DEVITA VT JR et al.1973; CANCER RES.; U.S.A.; DA. 1973; VOL. 33; NO 2; PP. 226-233; BIBL. 30REF.Serial Issue

PRELIMINARY CLINICAL TRIALS OF DICHLOROMETHOTREXATE (NSC-29630) IN HEPATOCELLULAR CARCINOMA = ESSAIS CLINIQUES PRELIMINAIRES DU DICHLOROMETHOTREXATE (NSC-29630) SUR LE CARCINOME HEPATOCELLULAIREVOGEL CL; ADAMSON RH; DEVITA VT et al.1972; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1972; VOL. 56; NO 2; PP. 249-258; BIBL. 19 REF.Serial Issue

A DECADE OF COMBINATION CHEMOTHERAPY OF ADVANCED HODGKIN'S DISEASEDEVITA VT JR; CANELLOS GP; MOXLEY JH III et al.1972; CANCER; U.S.A.; DA. 1972; VOL. 30; NO 6; PP. 1495-1504; BIBL. 35 REF.Serial Issue

EVIDENCE OF A TREATMENT DOSE RESPONSE IN ACUTE NONLYMPHOCYTIC LEUKEMIAS WHICH OCCUR AFTER THERAPY OF NON-HODGKIN'S LYMPHOMA = PREUVE D'UNE REPONSE LIEE A LA DOSE THERAPEUTIQUE DANS LES LEUCEMIES NON LYMPHOCYTAIRES AIGUES DEVELOPPEES APRES TRAITEMENT DES LYMPHOMES NON HODGKINIENSGREENE MH; YOUNG RC; MERRILL JM et al.1983; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1983; VOL. 43; NO 4; PP. 1891-1898; ABS. ENG; BIBL. 62 REF.; GRAPHArticle

DIBROMOMANNITOL IN THE THREATMENT OF CHRONIC GRANULOCYTIC LEUKEMIA: A PROSPECTIVE RANDOMIZED COMPARISON WITH BUSULFANCANELLOS GP; YOUNG RC; NIEMAN PE et al.1975; BLOOD; U.S.A.; DA. 1975; VOL. 45; NO 2; PP. 197-203; BIBL. 16REF.Article

PROLONGED DISEASE-FREE SURVIVAL IN HODGKIN'S DISEASE WITH MOPP REINDUCTION AFTER FIRST RELAPSEFISHER RI; DEVITA VT; HUBBARD SP et al.1979; ANN. INTERN. MED.; USA; DA. 1979; VOL. 90; NO 5; PP. 761-763; BIBL. 8 REF.Article

CHEMOTHERAPY (CYCLOPHOSPHAMIDE, VINCRISTINE, AND PREDNISONE) VERSUS RADIOTHERAPY (TOTAL BODY IRRADIATION) FOR STAGE III-IV POORLY DIFFERENTIATED LYMPHOCYTIC LYMPHOMA.JOHNSON RE; CANELLOS GP; YOUNG RC et al.1978; CANCER TREATM. REP.; U.S.A.; DA. 1978; VOL. 62; NO 3; PP. 321-325; BIBL. 16 REF.Article

  • Page / 3